|
Variable
|
P value
|
Odds ratio
|
95% CI
|
|---|
|
Pre-op Sarcopeniaa
|
0.5259
|
0.60
|
0.13 - 3.19
|
|
TPI reduction rate severe group
|
0.0074*
|
4.43
|
1.47 - 15.3
|
|
Age ≥ 66 y
|
0.0942
|
2.57
|
0.86 - 8.86
|
|
≥ ASA 3
|
0.0109*
|
8.33
|
1.62 - 62.47
|
|
Pre-op Albumin < 3.6 g/dL
|
0.7550
|
1.33
|
0.17 - 7.46
|
|
No preoperative therapy
|
0.0492*
|
3.16
|
1.00 - 10.21
|
|
No postoperative therapy
|
0.5367
|
0.72
|
0.25 - 2.03
|
|
Pre-op BMI < 18.5 kg/m2
|
0.3262
|
0.47
|
0.07 - 2.00
|
|
Open or TEPP
|
0.1053
|
2.45
|
0.83 - 7.33
|
|
Open or HALS
|
0.2610
|
1.84
|
0.63 - 5.35
|
|
LN dissection field (2-field / 3-field)
|
0.5692
|
1.36
|
0.48 - 4.15
|
|
Blood loss ( > 330 ml)
|
0.4524
|
1.49
|
0.53 - 4.29
|
|
Operation time ( > 616 min)
|
1.0000
|
1.0000
|
0.35 - 2.83
|
|
≥ pStage III
|
0.0012*
|
6.40
|
2.02 - 24.87
|
- Pre-op preoperative, TPI total psoas major muscle mass index, ASA the American Society of Anesthesia physical status, BMI Body mass index, TEPP Thoracoscopic esophagectomy in the prone position, HALS Hand-assisted laparoscopic surgery, LN lymph node, pStage pathological stage (UICC 8th), aAccording to the definition of Prado [22], *p value <0.05
